Eculizumab and renal transplantation in a patient with catastrophic antiphospholipid syndrome: Effect of heparin on complement activation

Lupus

Volumn 20, Issue 7, 2011, Pages 772-

  Velik Salchner, C ^a   Lederer, W ^a   Wiedermann, F J ^a  

^a INNSBRUCK MEDICAL UNIVERSITY   (Austria)

Author keywords

[No Author keywords available]

Indexed keywords

ECULIZUMAB; HEPARIN; PHOSPHOLIPID ANTIBODY;

ACUTE KIDNEY FAILURE; ANTICOAGULANT THERAPY; ANTICOAGULATION; ANTIPHOSPHOLIPID SYNDROME; COMPLEMENT ACTIVATION; ENZYME LINKED IMMUNOSORBENT ASSAY; HUMAN; KIDNEY TRANSPLANTATION; LETTER; NONHUMAN; PRIORITY JOURNAL; THROMBOTIC THROMBOCYTOPENIC PURPURA;

ANIMALS; ANTIBODIES, MONOCLONAL; ANTIBODIES, MONOCLONAL, HUMANIZED; ANTICOAGULANTS; ANTIPHOSPHOLIPID SYNDROME; COMBINED MODALITY THERAPY; COMPLEMENT ACTIVATION; DISEASE MODELS, ANIMAL; HEPARIN; HUMANS; KIDNEY TRANSPLANTATION;

EID: 79957595997     PISSN: 09612033     EISSN: 14770962     Source Type: Journal    
DOI: 10.1177/0961203310389099     Document Type: Letter

References (4)

1. Lonze BE, Singer AL, Montgomery RA. Eculizumab and renal transplantation in a patient with CAPS. N Engl J Med. 2010 ; 362: 1744-1745
2. Franklin RD, Kutteh WH. Effects of unfractioned and low molecular weight heparin on antiphospholipid antibody binding in vitro. Obst Gynecol. 2003 ; 101: 455-462 (Pubitemid 36288484)
3. Girardi G, Bulla R, Salmon JE, Tedesco F. The complement system in the pathophysiology of pregnancy. Mol Immunol. 2006 ; 43: 68-77 (Pubitemid 41021523)
4. Wiedermann FJ, Mayr A, Schobersberger W, et al. Acute respiratory failure associated with catastrophic antiphospholipid syndrome. J Intern Med. 2000 ; 247: 723-730 (Pubitemid 30430350)